Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition
NEW YORK, May 3, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Probiotics and Prebiotics in Clinical Nutrition
http://www.reportlinker.com/p0488805/Probiotics-and-Prebiotics-in-Clinical-Nutrition.html
Introduction
Overall sales of clinical nutrition products are rising with an aging population in the US and EU as well as rising incidence of illnesses and conditions that require clinical nutrition. But sales of clinical nutrition products containing probiotics and prebiotics are outpacing sales of conventional clinical nutrition products, opening up a new market that is dominated by a handful of players.
Features and benefits
* Understand the clinical nutrition market and broad trends affecting product development and usage.
* Analyze the unmet need for pro/prebiotic clinical nutrition products and what is the supporting clinical data for product benefits?
* Identify the key players in the pro/prebiotic clinical nutrition market and the leading products in the market.
* Forecast the growth of the pro/prebiotic clinical nutrition market by users and product sales in the EU and the US.
* Assess the future of probiotics and prebiotics in clinical nutrition and the potential product development opportunities.
Highlights
Nearly all of the major manufacturers of enteral nutrition products – Abbott Nutrition, Danone, Fresenius Kabi and Nestle – are currently working to expand their offerings of products containing probiotics and prebiotics. Currently, several clinical nutrition products are formulated with prebiotics and one major product contains probiotics.
Several special patient populations are especially good candidates for clinical nutrition products containing probiotics and/or prebiotics as they have specific and/or greater nutritional needs than non-elderly adults. They include the elderly, patients with compromised gastrointestinal systems, the critically ill and infants.
Although there is interest and activity in the development of enteral nutrition products containing probiotics, a lack of basic research establishing the clinical performance of probiotics in enteral nutrition patients is limiting further new product activity.
Your key questions answered
* Why are clinical nutrition products now incorporating probiotic and prebiotic ingredients? What types products are most amenable to reformulation?
* What benefits can probiotic and prebiotic ingredients provide in clinical nutrition products that is not otherwise available?
* What clinical nutrition products currently contain probiotic and prebiotic ingredients?
* Which patient groups/market segments are most attractive for these products?
* What is the forecast growth of clinical nutrition products containing probiotics and prebiotics and what are the drivers/inhibitors of R&D?
Executive Summary
Introduction to clinical nutrition
Probiotics and their role in healthcare
Usage of probiotics and prebiotics in clinical nutrition
Activities of the major players in probiotics and prebiotics
About the author
Disclaimer
Introduction to clinical nutrition
Summary
Introduction
Major types of clinical nutrition
Enteral nutrition
Parenteral nutrition
Infant nutrition
Patient populations
Cancer patients
Gastrointestinal disease patients
AIDS patients
Patients with neuromuscular conditions
Malnutrition patients
Other clinical nutrition patients
Environments for clinical nutrition
Inpatient environments
Outpatient environments
Regulation of clinical nutrition products
US
EU
Insurance coverage
EU
User populations
Conclusions
The evolving role of probiotics in healthcare
Summary
Introduction
Probiotics
Prebiotics
Synbiotics
Factors affecting probiotic levels in the human body
Declining levels of probiotics in food
Types of probiotic organisms
Safety issues
Probiotics
Prebiotics
Benefits of probiotics and prebiotics
Anxiety
Colon cancer
Diarrhea
Gastrointestinal disease and diarrhea
Helicobacter pylori
Hypertension
Immune system function
Lactose intolerance
Mineral absorption
Urinary tract infections
Yeast infections
Disadvantages of probiotics
Probiotics
Prebiotics
Patent issues
Regulation of probiotic and prebiotic products
US
EU
Other industry issues
Standards
Testing protocols
Consumers' ability to self-diagnose
Current products
Probiotics
Prebiotics
User populations
Probiotics
Prebiotics
Conclusions
Usage of probiotics and prebiotics in clinical nutrition
Summary
Introduction
Special populations
The elderly
Patients with compromised gastrointestinal systems
The critically ill
Infants
Safety issues
Current products
Products under development
Parenteral nutrition
Infant nutrition
Sales forecasts, 2010 - 2015
Total probiotic supplement sales by region, 2010 - 2015
Total prebiotic supplement sales by region, 2010–2015
Sales of clinical nutrition products containing probiotics, 2010–2015
Sales of clinical nutrition products containing prebiotics, 2010 - 2015
Conclusions
Activities of the major players in probiotic and prebiotic clinical nutrition products
Summary
Introduction
Leading suppliers of clinical nutrition products
Abbott Laboratories
B. Braun
Danone
Fresenius Kabi
Nestle
Pfizer
The future of probiotics and prebiotics in clinical nutrition
Conclusions
Appendix
Scope
Methodology
Secondary research
Glossary/Abbreviations
Bibliography/References
To order this report:
: Probiotics and Prebiotics in Clinical Nutrition
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article